U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07323680) titled 'Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects' on Dec. 18, 2025.

Brief Summary: The purpose of this study is to compare the safety, pharmacokinetics, and pharmacodynamic effects of aspirin administered intravenously with aspirin administered orally.

Study Start Date: June 15, 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: 325 mg Oral Aspirin

Drug: aspirin 325mg

* Subjects will be administered 325 mg aspirin orally

DRUG: 325 mg aspirin by rapid IV push

Drug: Rho-11 Subjects will be administered 325 m...